The University of Virginia has opened a state-of-the-art MR-guided focused ultrasound ablation research institute.
The University of Virginia has opened a state-of-the-art MR-guided focused ultrasound ablation research institute. It is designed to become a leading center for translational research and patient care in this new and rapidly evolving field, said provost Dr. Tim Garson on dedication day, Sept 14.
The UVA center will offer uterine fibroid therapy, the first application of the focused ultrasound technology to receive FDA approval. It will also host clinical trials on uterine fibroids and fertility; Parkinson’s disease and epilepsy; liver, brain, breast, and prostate tumors; and pain control from bone tumors. The state of Virginia and the Focused Ultrasound Surgery Foundation covered $7.1 million of the $8 million cost of establishing the institute. Other contributors included GE Healthcare and InSightec, developer of the first FDA-approved MR-guided focused ultrasound ablation system.
almost 17 years ago
Critical results still go unnoticed on patient EMRalmost 17 years ago
Coronary CTA exposes plaque risk for diabeticsalmost 17 years ago
Contrast media reactions rarely happen, study findsalmost 17 years ago
Women who skip mammo face higher risk of deathalmost 17 years ago
Rads urge cautious CT use for swine flu workupalmost 17 years ago
Berger urges imagers to be stewards of radiologyalmost 17 years ago
Disaster survivors show early signs of traumatic stressalmost 17 years ago
fMRI lights up gap between consciousness and cognitionalmost 17 years ago
A reply from Dr. Leonard Berlinalmost 17 years ago
Defending mammography in the face of continued attacks
